CCM
JAZZ icon

Cinctive Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cinctive Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,686
Closed -$6.56M – 491
2026
Q1 		$6.56M Buy
34,686
+28,347
+447% +$4.95M 0.43% 78
2025
Q4 		$1.08M Buy
+6,339
New +$972K 0.06% 274
2025
Q1 		– Sell
-47,765
Closed -$5.88M – 397
2024
Q4 		$5.88M Sell
47,765
-80,382
-63% -$9.47M 0.3% 112
2024
Q3 		$14.3M Buy
+128,147
New +$14M 0.78% 29

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Cinctive Capital Management's JAZZ Position: Q2 2026 in Review

Cinctive Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 34,686 shares — an estimated $6.56M sold.

Cinctive Capital Management first reported a position in JAZZ in Q3 2024 and held it in 4 quarters. The position peaked at $14.3M in Q3 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Cinctive Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 34,686 Jazz Pharmaceuticals shares in Q2 2026, an estimated $6.56M.
  • Cinctive Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Cinctive Capital Management's Jazz Pharmaceuticals position peaked at $14.3M in Q3 2024.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.